NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: University Hospital, Basel, Switzerland
Conditions: Multiple Sclerosis (MS)
Interventions: Neurostatus-SMARTCARE, Standard Neurostatus-EDSS
Countries: Switzerland
The Expanded Disability Status Scale (EDSS) is the gold-standard in assessing disability in Multiple Sclerosis (MS). Its current digital form, the Neurostatus-eEDSS®, often serves as primary endpoint in MS clinical trials. The pandemic revealed the need for telemedical alternatives to the in-clinic assessment. Therefore, Neurostatus-SMARTCARE was developed: A trained and certified non-neurologist Health Care Professional (HCP) examines the patient while the examination is being video-recorded. The stored video allows a neurologist to re-assess the examination at a later point of time. The future application could be in-home visits through HCPs, in decentralized clinical trials as well as in routine care. In this study, the concordance rate of Neurostatus examinations between neurologists and HCPs is investigated. With a concordance rate significantly higher than 80%, Neurostatus-SMARTCARE by HCPs can be considered equal to the standard Neurostatus-EDSS by neurologists.
Sex: ALL
Age: 18 Years to —
Healthy volunteers: No
Study type: INTERVENTIONAL
Inclusion Criteria: * 18 years old at the time of signing the informed consent * Clinically definite MS, confirmed through the medical chart * At least one documented EDSS assessment within two (2) years prior to inclusion * The participant must be capable of giving signed informed consent Exclusion Criteria: * Insufficient knowledge of the German language, i.e. inability to understand the patient information or to follow the instructions and questions during the EDSS assessment
- Basel, Switzerland
- Lucerne, Switzerland